Filing Details
- Accession Number:
- 0001209191-21-011547
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-17 20:00:42
- Reporting Period:
- 2021-02-14
- Accepted Time:
- 2021-02-17 20:00:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1478320 | Adaptive Biotechnologies Corp | ADPT | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1274139 | Robert Hershberg | C/O Adaptive Biotechnologies Corp. Suite 200 Seattle WA 98102 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-02-14 | 1,504 | $0.00 | 1,504 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2021-02-16 | 2,000 | $0.45 | 3,504 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-02-16 | 2,000 | $65.45 | 1,504 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2021-02-14 | 3,759 | $0.00 | 3,759 | $66.50 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2021-02-16 | 2,000 | $0.00 | 2,000 | $0.45 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 3,759 | 2031-02-14 | No | 4 | A | Direct | |
| 55,000 | 2023-02-04 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2020.
- The option will vest in equal monthly installments over one year, subject to continued service as a director through such vesting date.
- The option is fully vested and exercisable.
Billionaire Hedge Funds
